ABS is pioneering a personalized, genetically guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7 receptor. HOUSTON, Nov. 19, 2025 /PRNewswire/ -- Autoimmunity ...

This rare genetic disorder can affect your nerves and cause tumors on the brain and spinal cord that may impact hearing, vision, and balance. Proper treatment and regular monitoring can help manage ...

ABS is pioneering a personalized, genetically guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7 receptor. "I am very grateful that each of these highly experienced ...

GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN ® ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Koselugo’s approval was based on data from the phase 3 ...

The FDA has approved selumetinib (Koselugo, AstraZeneca) for adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). With the new regulatory decision, ...

Selumetinib received FDA approval for adults with NF1 and symptomatic, inoperable plexiform neurofibromas, based on the phase 3 KOMET trial results. The KOMET trial showed a 20% objective response ...

This genetic condition causes tumors to form on nerves throughout the body, often showing up as skin changes. The right treatment and management approach can help address symptoms and potential ...

Merlin is closely related to ezrin, radixin and moesin (ERMs) — membrane–cytoskeleton-associated proteins that belong to the protein 4.1 superfamily. Although merlin is the only member of the ...

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product ...